FDA Panel Applauds Maestro Weight Loss Device, Despite Efficacy Shortfall
This article was originally published in The Gray Sheet
Executive Summary
An advisory panel voted in support of EnteroMedics’ Maestro Rechargeable System, despite the device’s failure to meet its primary effectiveness endpoints. The implantable device is intended to stimulate the vagus nerve to achieve weight reduction in obese patients.